Optiscan Imaging Limited is an Australia-based company engaged in the development of microscopic imaging and related technologies for surgery and medical research. The Company has developed and commercialized confocal microscopes for clinical and pre-clinical applications. Its endomicroscopic technology enables 3D, in-vivo imaging of human tissue at the cellular level for cancer screening, diagnoses and in surgery. Its InVivage device is developed for clinical use in the oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a miniaturised confocal endomicroscope used for cellular level in-vivo imaging in living tissues. The Company also provides customization options for its product, (FIVE2).

Sales Analysis. Optiscan Imaging Ltd reported sales of A$889,526.00 (US$644.59 thousand) for the fiscal year ending June of 2021. This represents a sharp decrease of 25.3% versus 2020, when the company's sales were A$1.19 million.